. Currently, she is interested in understanding the mechanisms that regulate selfrenewal and differentiation of human embryonic stem cells.
Introduction
Human embryonic stem cells (ESC) were first derived by growing them on a layer of mouse embryonic fibroblast (MEF) feeder cells in medium supplemented with fetal bovine serum (FBS; Reubinoff et al., 2000; Thomson et al., 1998) . However, culture conditions that include animal-derived cells and serum are not suitable for clinical applications. Of the many types of feeders derived from different types of human cells tested for their capacity to support undifferentiated growth of human ESC (Amit et al., 2003; Cheng et al., 2003; Lee et al., 2004 Lee et al., , 2005 Richards et al., 2002 Richards et al., , 2003 Stojkovic et al., 2005b; Wang et al., 2005) , human foreskin fibroblasts (HFF), those produced under good manufacturing conditions for clinical purposes, appear to be the most suitable (Hovatta et al., 2003; Ilic et al., 2009; Inzunza et al., 2005; Unger et al., 2008) . Nonetheless, the development of a defined, cell-free substrate for the cultivation of human ESC represents the next step towards using human ESC in cell replacement therapies. For example, extracellular matrix components of human origin, including laminin (Li et al., 2005; Vuoristo et al., 2009) , vitronectin (Braam et al., 2008b) , fibronectin (Amit et al., 2004; Braam et al., 2008b) , collagen IV (Braam et al., 2008b) and human serum matrix (Stojkovic et al., 2005a) have been tested.
Efforts towards developing a serum-free medium have also made significant progress. For example, knockout serum replacement (KSR) supports undifferentiated growth and high cloning efficiency of human ESC (Amit et al., 2000) . However, animal-derived components in KSR still represent a potential source of immunogenic compounds (Martin et al., 2005) , retroviruses and other pathogens (Halme and Kessler, 2006) . Conditioned medium from mouse feeder cells can also be used in combination with KSR for feeder-free culture of human ESC, but it contains cellmembrane-derived microvesicles that carry immunogenic and pathogenic agents (Hisamatsu-Sakamoto et al., 2008; Kubikova et al., 2009) . As microvesicles persist in conditioned medium for an unknown period of time and have been shown to infect human ESC, they represent a serious obstacle for various culture platforms.
Importantly, the addition of growth factors, such as fibroblast growth factor 2 (FGF-2; Levenstein et al., 2006; Li et al., 2005; Xu et al., 2005b) , Noggin (Xu et al., 2005a) or activin A (Beattie et al., 2005; Xiao et al., 2006) , can substitute for both conditioned medium and KSR. Based on these findings, many commercially available, defined media, such as the bovine serum albumin-containing StemPro (Invitrogen), mTeSR 1 StemCell Technologies) and HESGRO (Millipore) and the animal protein-free TeSR 2 (StemCell Technologies) were developed. mTeSR 1 and StemPro are the most widely used alternatives to MEF-conditioned media, but still contain components of animal origin and high concentrations of growth factors, which are expensive to produce.
Another avenue of investigation is the development of plant-derived serum replacements that can be produced in high quantity and with easy quality control. Plant hydrolysates are widely used as medium additives or replacements for FBS and other bovine extracts in cultures of hybridomas (Franek et al., 2000; Zhang et al., 1994) , keratinocytes (Lee et al., 2008) , Chinese hamster ovary cells (Chun et al., 2007) , primary rat hepatocytes (Hamel et al., 2006) , BHK-21 cells (Heidemann et al., 2000) and insect cells (Kwon et al., 2005) .
This study tested the plant product VegetaCell, which has been shown to promote the survival of hybridoma cells and the production of monoclonal antibodies (Franek et al., 2000 (Franek et al., , 2003 . VegetaCell is a hydrolysate from the gluten of spelt wheat that is purified by ultracentrifugation and size-exclusion chromatography. It contains specific groups of oligopeptides up to 500 Da and therefore represents a well-defined substance. Thus, when combined with humanized reagents, VegetaCell supplement has a potential to be used for generation of clinical grade pluripotent stem cells and their derivatives.
Materials and methods

Culture of human ESC
Karyotypically normal human ESC lines CCTL14 (46,XX; at passages 23-45) and CCTL12 (46,XX; at passages 28-39) were routinely maintained in DMEM/F12 supplemented with 15% KSR, 2 mmol/l L-glutamine, 1· MEM non-essential amino acid solution, 50 U/ml penicillin, 50 lg/ml streptomycin (Invitrogen, Carlsbad, CA, USA), 100 lmol/l b-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA) and 10 ng/ml human recombinant FGF-2 (Peprotech, Rockyhill, NY, USA) on irradiated (50 Gy) MEF feeder cells (from CF-1 strain; at the density of 22,500/cm 2 ). Enzymatic passaging was routinely performed using type IV collagenase (1 mg/ml; Invitrogen). For preparation of the human feeder layer, HFF (SCRC 1041; American Type Culture Collection, Manassas, VA, USA) were irradiated (50 Gy) and plated at a density of 45,000/cm 2 . For standard culture of human ESC in feeder-free conditions, Matrigel human ESC-qualified matrix (BD Biosciences, Bedford, MA, USA) was used in combination with MEF-conditioned KSR medium supplemented with 10 ng/ml of FGF-2 and sterile-filtered. For passaging on Matrigel, type IV collagenase was used for colonies and TrypLE Select (Invitrogen) was used for monolayers of human ESC.
For optimizing the animal protein-free medium (VegetaCell medium), the protocol used VegetaCell (Chemispol, Kutna Hora, Czech Republic), human serum albumin (HSA; Sigma-Aldrich), 250· cholesterol lipid concentrate (Invitrogen), L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma-Aldrich), human holo-transferrin (Sigma-Aldrich), human insulin (Sigma-Aldrich) and sodium selenite (Sigma-Aldrich).
Semiquantitative reverse-transcription and quantitative real-time polymerase chain reaction Pellets of cells in RNAlater (Qiagen, Valencia, CA, USA) were stored at À80°C until total RNA was isolated using the RNeasy Micro Kit (Qiagen).
For semiquantitative reverse-transcription polymerase chain reaction (RT-PCR), cDNA was synthesized by M-MLV reverse transcriptase (Invitrogen) at 37°C for 1 h followed by 15 min at 65°C. Consequent PCR included denaturation at 94°C for 4 min followed by repeated cycles of 94°C for 30 s, annealing temperature for 30 s and extension at 72°C for 1 min; the final extension step proceeded at 72°C for 5 min. PCR primers (Generi-Biotech, Hradec Kralove, Czech Republic) and reaction conditions used are described in Supplementary Table 1 (online only). GAPDH was used as the positive control. PCR products were size fractionated by 1.5% agarose gel electrophoresis.
For quantitative real-time (qRT-PCR), cDNA was synthesized by Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Science, Mannheim, Germany). PCR conditions were as follows: initial denaturation at 95°C for 10 min followed by repeated cycles of 95°C for 15 s and 60°C for 1 min. TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, USA) for NANOG (Hs02387400_g1), TDGF1 (Hs02339499_g1), GABRB3 (Hs00241459_m1), DNMT3B (Hs00171876_m1), GDF3 (Hs00220998_m1), POU5F1 (Hs00742896_s1), GAL (Hs0054433 5_m1), LEFTB (Hs00764128_s1) and GAPDH (4333764F) were performed on a LightCycler 480 II (Roche) according to the manufacturer's instructions. Relative mRNA concentrations were normalized to GAPDH.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde and blocked with 3% goat serum, 0.03% Tween in phosphate-buffered saline (PBS) on ice. For detection of nuclear proteins, 10-min incubation with 0.05% Triton X-100/PBS preceded the blocking step. After that, cells were incubated with primary antibodies at 4°C overnight. Primary antibodies included rat monoclonal anti-SSEA3 (MAB4303; Chemicon International, Temecula, CA, USA), mouse monoclonal anti-SSEA4 (MAB4304; Chemicon), mouse monoclonal anti-TRA-1-60 (MAB4360; Chemicon), mouse monoclonal anti-TRA-1-81 (MAB4381; Chemicon), mouse monoclonal anti-Oct4 (sc-5279; Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit polyclonal anti-NANOG (sc-33759; Santa Cruz Biotechnology) and mouse monoclonal anti-b-tubulin III (11-264-C100; EXBIO Praha, Vestec, Czech Republic). After washing out the unbound primary antibody, cells were incubated with appropriate secondary antibodies conjugated with Alexa Fluor 488 (A11008; Invitrogen), Alexa Fluor 594 (A11005; Invitrogen) or fluorescein isothiocyanate (FITC; ab20087; Abcam, Cambridge, UK). Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI). Microscopic analysis was performed using a FluoView 500 laser scanning microscope (Olympus, Prague, Czech Republic) or a IX71 inverted fluorescence microscope with a CC-12 digital camera (Olympus).
Flow cytometry
Cells were dissociated to single-cell suspension with 0.5 mmol/l EDTA/PBS. Then, cells were incubated with primary antibodies diluted in 10% FBS/PBS for 30 min on ice. Rat monoclonal anti-SSEA3 and mouse monoclonal anti-TRA-1-81 were provided by Prof Peter W Andrews (Department of Biomedical Science, University of Sheffield) and used to detect cell-surface-antigen expression. Secondary antibody was FITC-conjugated goat anti-mouse IgG + IgM (M30801; Caltag-Medsystems, Buckgingham, UK). Cells were counterstained with propidium iodide and analysed using a Cytomics FC500 cytometer (Beckman Coulter, Fullerton, CA, USA). At least 10,000 FITC-positive propidium iodidenegative cells were included in each analysis.
Alkaline phosphatase activity assay
Human ESC were fixed in 4% paraformaldehyde for 2 min and the activity of alkaline phosphatase was visualized using alkaline phosphatase blue microwell substrate (Sigma-Aldrich), according to the manufacturer's instructions.
Proliferation assays
Proliferation of human ESC was measured either by WST-1 reagent (Roche) or by cell counting (for human ESC growing in feeder-free conditions). For the WST-1-based proliferation assay, human ESC were seeded into 96-well plates at a concentration of about five colonies per well. After 24 h, 10 ll of the WST-1 reagent was added to 100 ll of the culture media. After 3 h of incubation at 37°C, absorbance of the media was measured using a DTX 880 Multimode Detector (Beckman Coulter) for 6 days. Cultures with feeder cells but without human ESC were used as a background control.
To measure the proliferation of human ESC growing in feeder-free conditions, cells dissociated into a single-cell suspension were seeded at an initial density of 90,000 cells/well in 24-well plates. The cell counts were determined using a ViCell XR (Beckman Coulter) at 24-h intervals for 5 days. In the exponential phase of the cell growth, the doubling time (t) was calculated using the formula t = (T · log 2)/log(y/y 0 ), where T represents the time interval used for calculation (usually 48 h, determined from the growth curve) and y 0 and y are the average cell counts at the beginning and end of the time-interval, respectively.
5-Ethynyl-2-deoxyuridine incorporation assay
To determine the duration of the cell cycle, 5-ethynyl-2 0 -deoxyuridine (EdU; Click-iT EdU Alexa Fluor 594 High-Throughput Imaging Assay; Invitrogen) was added at a final concentration of 5 lmol/l to the culture media of human ESC at the beginning of the exponential growth (usually after 48 h on feeder cells and 24 h in monolayer culture on Matrigel). After appropriate incubation (30 min and 8, 9, 10, 11 and 12 h), cells were fixed in 4% paraformaldehyde for 15 min, blocked with 4% goat serum, 0.1% Triton X-100/PBS on ice for 15 min and incubated with the reaction cocktail according to the manufacturer's instructions. Nuclei were counterstained with DAPI. Photos were taken using an inverted fluorescence microscope.
For each labelling interval, the percentage of EdU-positive cells was determined in at least 2000 cells counterstained with DAPI. The percentage of EdU-positive cells (% 30pos ) in the shortest incorporation interval (experimentally determined as 30 min) represents the number of cells in S-phase. The incorporation interval when the percentage of EdU-positive cells reaches its maximum (T max ; 8-12 h tested) indicates the time, when cells that were previously in other phases of the cell cycle (100-% 30pos ) reached S phase.
The total duration of the cell cycle (t) was calculated by following formula: t = (% 30pos · T max )/(100-% 30pos ) + T max .
In-situ TdT (terminal deoxynucleotidyl transferase)-mediated dUDP nick-end labelling assay Human ESC were fixed in 1% paraformaldehyde at room temperature for 10 min and post-fixed in precooled ethanol:acetic acid (2:1, v/v) for 5 min on ice. Then, staining was performed using the ApopTag Plus Fluorescein In situ Apoptosis Detection Kit (Chemicon), according to the manufacturer's instructions. The percentage of apoptotic cells was determined microscopically using a laser scanning microscope. A minimum of 5000 cells was used for each experiment.
Differentiation of human ESC
For embryoid body (EB) differentiation, human ESC were dissociated to single-cell suspension with 0.5 mmol/l EDTA/PBS and seeded in EB differentiation medium, consisting of DMEM supplemented with 10% FBS (Invitrogen), 2 mmol/l L-glutamine, 1· MEM non-essential amino acid solution, 50 U/ml penicillin, 50 lg/ml streptomycin and 100 lmol/l b-mercaptoethanol, into AggreWell plates (StemCell Technologies) at the density of 2000 cells per microwell. After 12 h, human ESC aggregates were transferred to non-adherent culture dishes and cultured for the next 5 days with daily change of medium. Then, well-developed EB were transferred to adherent conditions into gelatin-coated wells and cultured for 10 days according to previously described differentiation protocol (5 + 10 day differentiation protocol; Dvorak et al., 2005) . Simultaneously, control group of EB was maintained in non-adherent culture for 20 days after initial period of aggregation.
To derive neural precursor cells and neuron-like cells from human ESC expanded in medium with VegetaCell, cells were aggregated using AggreWell plates in 50% DMEM/F12 and 50% Neurobasal medium supplemented with N-2 and B-27 Supplements (all from Invitrogen), 2 mmol/l L-glutamine, 1· MEM non-essential amino acid solution, 50 U/ml penicillin, 50 lg/ml streptomycin, 100 lmol/l b-mercaptoethanol and 20 ng/ml human recombinant FGF-2 (neurodifferentiation medium). Cell aggregates were then transferred to non-adherent culture dishes and on days 6, 10 and 14, neurodifferentiation medium was changed and supplemented with 0.5 lmol/l all-trans-retinoic acid. At day 16, EB were harvested, dissociated with Accutase (Sigma-Aldrich) and single-cell suspension rarely containing cell clumps was plated into gelatin-coated dishes in neurodifferentiation medium from which Neurobasal medium was omitted. The total time for neurodifferentiation protocol was 20-25 days.
Karyotype analysis
Human ESC were incubated with 0.08 lg/ml of KaryoMAX Colcemid solution (Invitrogen) for 4 h at 37°C to arrest cells in metaphase. A suspension of human ESC was then placed in hypotonic 0.0375 mol/l KCl solution and fixed in methanol:acetic acid (3:1, v/v). After G-banding, cells in metaphase were kindly analysed by Dr. Duncan Baker (Sheffield Diagnostic Genetic Services, Centre for Stem Cell Biology, University of Sheffield).
Results
Development and optimization of human ESC culture in humanized medium with VegetaCell
Since human ESC are highly sensitive to changes in the culture conditions, human ESC that had been routinely maintained on MEF feeders to growth on HFF and Matrigel were first adapted by growing them for three passages in their new conditions. Human ESC colonies grown on HFF were more compact and spindle-shaped than those growing on MEF feeder cells. In addition, 60-80% of colonies developed a peripheral layer of morphologically distinct cells ( Figure 1A-C) . For feeder-free culture of human ESC, a two-step adaptation process was performed. First, human ESC were dissociated into small clumps using collagenase and were transferred onto Matrigel-coated dishes in MEF-conditioned KSR-based medium. Well-developed human ESC colonies were treated with TrypLE to obtain a single-cell suspension and were plated at high density to achieve confluence within 2 days.
After stepwise adaptation of human ESC on HFF, human ESC were transferred into medium containing DMEM/ F12, 2 mmol/l L-glutamine, 1· MEM non-essential amino acid solution, 50 U/ml penicillin, 50 lg/ml streptomycin, 100 lmol/l b-mercaptoethanol, 10 ng/ml FGF-2, supplemented with 5.5 lg/ml human holo-transferrin, 1 lg/ml human insulin, 0.8 lg/ml sodium selenite, several concentrations of HSA (0-40 mg/ml) and VegetaCell serum replacement (0-20%). Under these conditions, even with increased concentrations of HSA and VegetaCell, human ESC grew for maximum of three passages (Supplementary  Table 2 ; online only). Thus, the medium was further supplemented with 0.4% cholesterol mixture and 50 lg/ml L-ascorbic acid salt. These additives significantly improved growth of human ESC, specifically at concentrations of 5-10% VegetaCell and 5-10 mg/ml HSA (Supplementary  Table 2 ). Notably, when cells were grown on HFF and medium with VegetaCell, the layer of morphologically distinct cells surrounding colonies in KSR medium was not observed (compare Figure 1C and D) . Thus, using an optimized media with 5% or 10% VegetaCell and 5 or 10 mg/ml HSA, morphologically normal human ESC can be maintained.
Next, medium with VegetaCell in a feeder-free culture system with Matrigel was used, with the control as MEF-conditioned medium with KSR. Surprisingly, long-term culture of human ESC as low-density colonies ws not possible using medium with VegetaCell (about 50 colonies per 5-cm Petri dish; compare Figure 2A and B), but this was overcome by increasing the initial density of cells in monolayer culture (about 50,000 cells/cm 2 ). These results indicate that increased cell-to-cell signalling in highdensity cultures can compensate for the absence of conditioned media ( Figure 2C and D) . It was also shown that human ESC cultured at high density can revert to standard growth conditions either on a feeder layer (MEF feeder cells or HFF) or on Matrigel (data not shown).
Human ESC grown in medium with VegetaCell express markers of pluripotent cells and retain normal karyotype
To examine the undifferentiated status of human ESC growing in medium with VegetaCell, either on HFF or in feeder-free culture on Matrigel, this study used the following markers: POU5F1, NANOG, SOX2, TDGF1, GABRB3, DNMT3B, GDF3, GAL and LEFTB and the cell-surface markers SSEA3, SSEA4, TRA-1-60 and TRA-1-81. Semiquantitative RT-PCR, immunocytochemistry and flow cytometry showed comparable expression of markers of undifferentiated human ESC at all culture conditions tested ( Figure 3A- C and E). Similarly, human ESC grown in medium with VegetaCell exhibited strong alkaline phosphatase activity (Figure 3D) . For more precise comparison of gene marker expression in human ESC maintained under different culture conditions, qRT-PCR was used. This assay showed differences in the expression of NANOG, TDGF1, GABRB3, DNMT3B, GDF3 and POU5F1 that, however, did not exceed two-fold ( Figure 3F ). The exceptions were GAL and, more interestingly, LEFTB, where a monolayer culture with MEF-conditioned medium produced more than a six-fold increase compared with a standard culture with feeder layer. This result raises the possibility that monolayer culture with MEF-conditioned medium supports neuroectoderm differentiation pathway (Smith et al., 2008) .
Next, it was determined whether human ESC maintained in medium with VegetaCell retain a normal karyotype after prolonged cultivation. G-banding showed normal karyotypes in human ESC that were maintained as colonies on HFF and as feeder-free culture for at least 10 and 15 passages (Supplementary Figure 1 ; online only).
Medium with VegetaCell causes slower proliferation and longer cell cycles, but leads to decreased apoptosis in human ESC
To further substantiate the use of the novel humanized medium with VegetaCell for culturing human ESC, this study examined the cell proliferation rate, duration of the cell cycle and level of cell death in various VegetaCell-based culture settings compared with standard culture conditions with feeder cells and KSR (colony growth) and MEFconditioned medium on Matrigel (monolayer system). First, using metabolic WST-1 proliferation assay, which is suitable to measure growth of human ESC in the presence of feeder cells, it was determined that human ESC maintained in medium with KSR on HFF grew more slowly compared with human ESC maintained on MEF feeder cells. Although this difference was not significant, the same trend was observed in several experiments. This study also compared the growth of human ESC on a HFF feeder layer in KSR medium and in the medium with VegateCell. A reproducible decrease in the proliferation rate was observed in cells maintained in medium with VegetaCell ( Figure 4A) .
Next, the proliferation of human ESC growing as a feeder-free monolayer on Matrigel was measured. Since these cells could be dissociated into a single-cell suspension, proliferation rates were determined by cell counting. 4 cells in MEF-conditioned medium with KSR were counted 24 h after plating (Figure 4B ). However this lower plating efficiency did not influence doubling time, which was on average 34.9 h in MEF-conditioned medium with KSR and 32.4 h in medium with VegetaCell.
To complement the data obtained from the WST-1 metabolic assay and cell counts, an EdU incorporation assay was used to determine the duration of the cell cycle of human ESC growing in all culture conditions. Importantly, culture of human ESC on HFF prolonged the cell cycle by about 5 h compared with culture on MEF feeder cells. By contrast, culture of human ESC on HFF and Matrigel resulted in nearly the identical cell cycle duration. Compared with human ESC cultured on HFF or Matrigel in medium with KSR, a non-significant but reproducible prolongation of the cell cycle was observed when VegetaCell replaced KSR. These results correspond to the results obtained from proliferation assays and are shown in Figure 4C .
This study next examined whether apoptosis could contribute to the lower proliferation rates of human ESC in medium with VegetaCell. Results from an in-situ TdT (terminal deoxynucleotidyl transferase)-mediated dUDP nick-end labelling assay showed, that the apoptosis level is significantly higher in human ESC cultured on HFF compared with that of human ESC cultured on MEF feeder cells (a = 0.01) or Matrigel (a = 0.05). Notably, medium with VegetaCell significantly decreased the level of apoptosis in human ESC cultured on HFF (a = 0.05). A similar but non-significant trend was observed in human ESC maintained as a monolayer on Matrigel, as shown in Figure 4D .
In conclusion, human ESC cultured in medium with VegetaCell showed longer cell cycles and a reduced proliferation rate but a decreased level of apoptosis.
Differentiation capacity of human ESC grown in medium with VegetaCell
To evaluate the differentiation potential of human ESC maintained in medium with VegetaCell, the development of EB derived from cells maintained under standard conditions on MEF feeder cells and KSR was compared with cells maintained for 10 passages in monolayer culture and medium with VegetaCell. This comparison showed a high level of similarity between both groups of 20-day-old EB involving morphology and kinetics of cavitation ( Figure 5A) . To quantify the differentiation potential of human ESC maintained with VegetaCell, 5-day-old EB were plated into gelatin-coated dishes and EB-derived overgrowths were cultured for the next 10 days ( Figure 5A ). Semiquantitative RT-PCR for mesodermal, endodermal and ectodermal gene markers indicated that both culture conditions produce cells maintaining similar capacity to differentiate into all three germ layers ( Figure 5B) .
To further test whether EB derived from human ESC expanded in medium with VegetaCell show neurogenic potential, cells were cultured in neurodifferentiation medium and immunostained cells that were neuron-like in morphology for neuronal marker b-tubulin III were observed. This showed that human ESC maintained in VegetaCell medium and stimulated to neurodifferentiation produce first neural precursors and then b -tubulin III-positive neuron-like cells ( Figure 5C ). The presence of neural differentiation was also determined by semiquantitative RT-PCR for neural gene markers, which showed that the Quantitative real-time PCR revealed differences in the expression of NANOG, TDGF1, GABRB3, DNMT3B, GDF3, POU5F1, LEFTB and GAL between standard human ESC culture on mouse embryonic fibroblast (MEF) feeder cells in knockout serum replacement (KSR) medium and monolayer culture in VegetaCell medium. The control was a sample without cDNA. FITC = fluorescein isothiocyanate; MEF-CM = MEF-conditioned medium; ML = monolayer culture. Bars = 100 lm.
Development of new culture medium for human pluripotent stem cellsneurodifferentiation from human ESC maintained in medium with VegetaCell, generated cells with lower expression of NOG, NCAM, PAX6 and SOX2, while the expression of SOX10 and VIM was similar to that determined in neural cells generated from human ESC cultured under standard conditions ( Figure 5D ).
Discussion
For human ESC to be a source of cells for cell replacement therapies, they must be expanded and/or differentiated in medium that does not contain any potentially harmful agents. The culture medium for production of clinical grade cells must be of high, standardized quality and relatively inexpensive to produce the large numbers of cells needed for most therapeutic purposes. In the past, many new types of feeder layers, synthetic matrices and culture media have been developed and tested, with the ultimate goal of developing a chemicallydefined, humanized medium and a well-defined, cell-free substrate of non-animal origin. Unfortunately, many culture media currently require a mixture of growth factors at high concentrations, which makes them extremely expensive.
This study developed a culture medium based on several humanized reagents and the easily available and inexpensive spelt gluten hydrolysate VegetaCell. The medium does not require any extra doses of growth factors. In addition to the easy availability and low cost of plant origin serum replacements, another advantage is the increased safety. It is generally accepted that plant pathogens that might be present in plant-derived biological products are not pathogenic for mammalian cells. One potential exception may be plant-derived products containing immunogenic glycans (Gomord et al., 2005) . However, hydrolysis, ultracentrifugation and size-exclusion chromatography to isolate oligopeptides up to 500 Da in size nearly eliminates this concern. In the complete medium with VegetaCell, several reagents of human origin were also used. In addition to their relatively high cost, batch-to-batch variability may cause problems, so further efforts should be focused on human recombinant protein use.
The most critical step in testing of any new formula for a medium, serum supplement or altered manipulation is the Figure 4 Growth characteristics of human embryonic stem cells (ESC) maintained in different culture systems. (A) Metabolic activity of human ESC determined by a WST-1-based proliferation assay showed that human ESC on mouse embryonic fibroblast (MEF) feeder cells in medium with knockout serum replacement (KSR) grew better than human ESC on human foreskin fibroblasts (HFF) in medium with KSR, which grew better than human ESC on HFF in medium with VegetaCell. (B) Cell counts were used to establish the growth curve of monolayer human ESC. Doubling time determined at time period between 72 and 120 h after plating was comparable for both culture media tested. (C) A 5-ethynyl-2 0 -deoxyuridine incorporation assay showed longer cell cycles in human ESC maintained on HFF and Matrigel compared with standard culture on MEF feeder cells. This prolongation was even more pronounced in VegetaCell medium. (D) TdT (terminal deoxynucleotidyl transferase)-mediated dUDP nick-end labelling assay revealed that culture of human ESC on HFF significantly increased the number of apoptotic cells compared with culture on MEF feeder cells, while monolayer culture on Matrigel did not. Importantly, VegetaCell medium reduced the level of cell death in both culture systems. A two-tailed Student's t-test was used to determine the significance level. *P = 0.05; **P = 0.01; ***P = 0.001. cell adaptation to changed conditions. This is even more critical with human pluripotent stem cells, which are very fragile and sensitive to culture condition changes. Adaptation to a new medium could be performed in two ways: (i) growing the cells in a mixture of the new and original medium for several days, gradually increasing the proportion of the new medium; and (ii) direct transfer to the new medium with a transitory period of decreased viability and slower growth rate. The first option seems to be advantageous for some media, but apparently does not work for others (Rajala et al., 2007) . On the other hand, the direct transfer of cells to the new medium could cause cell death, potentially leading to selective pressure.
The current experiments applied a two-step adaptation strategy. First, human ESC, which were originally expanded on MEF feeders in standard medium with KSR, were transferred to culture on HFF in medium with KSR and to monolayer culture on Matrigel in MEF-conditioned medium. For the next three passages, human ESC morphology was monitored and the level of cell death was estimated by quantifying floating cells or cell debris. As a second step, standard medium with KSR and/or MEF-conditioned medium was converted into medium with VegetaCell.
In all culture systems, the cell cycle duration and level of cell death was measured. Notably, in comparison with standard culture on MEF feeder cells, culture of human ESC on HFF or Matrigel resulted in significantly prolonged cell cycles. In addition, it was observed that medium with VegetaCell caused further, yet non-significant, cell cycle prolongation. Interestingly, simple transfer of human ESC from culture on MEF feeder cells to HFF significantly elevated the apoptosis level. However, medium with VegetaCell, either in combination with HFF or Matrigel, produced human ESC with an apoptosis level close to that observed in a standard culture on MEF feeder cells. This apoptosis decrease corresponds with previously published data on the anti-apoptotic effect of VegetaCell (Franek, 2004; Franek and Katinger, 2002) . These results could serve as an explanation for a discrepancy between slightly prolonged cell cycles and shorter doubling time in cells cultured on Matrigel in medium with VegetaCell compared with cells growing on the same substrate with MEF-conditioned medium. Perhaps the best human ESC culture system employing the humanized medium with VegetaCell is a monolayer feeder-free system. This study showed that human ESC maintained as a monolayer in medium with VegetaCell for more than 15 passages retain a normal karyotype and express markers of undifferentiated cells. These cells also showed differentiation potential similar to that of human ESC maintained under standard culture conditions with feeder cells and KSR, although two observations (see Figures 3F and 5D) indicate some quantitative changes. Still, it remains to be investigated whether these changes in the expression of pluripotency and neurodifferentiation genes have any biological significance. Moreover, it was found that cells maintained in a monolayer again form colonies when transferred back onto feeder layers. These results agree with previously published data (Braam et al., 2008a ). This study was also able to omit the feeder cell-conditioned medium that represents a major barrier for the use of human ESC in cell therapy. So far, feeder-free culture has been used only in combination with feeder cell-conditioned medium or high concentrations of growth factors. The present study found that human ESC grow better in medium with VegetaCell and standard concentration of FGF-2 at high densities, supporting a model in which human ESC self-renewal is maintained by intrinsic signals (Eiselleova et al., 2008) .
In conclusion, the results of this study offer a new medium for the cultivation of human ESC and eventually human induced pluripotent stem cells that is based on a plant-derived serum replacement and humanized reagents. This medium is suitable not only for use in cell replacement therapy but also for drug testing (Desbordes et al., 2008) , more efficient human ESC transfection (Braam et al., 2008a) and growth factor signalling studies (Stewart et al., 2008) .
